27 related articles for article (PubMed ID: 12646415)
1. USP7 regulates ALS-associated proteotoxicity and quality control through the NEDD4L-SMAD pathway.
Zhang T; Periz G; Lu YN; Wang J
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28114-28125. PubMed ID: 33106424
[TBL] [Abstract][Full Text] [Related]
2. TGFβ1 Induces Axonal Outgrowth via ALK5/PKA/SMURF1-Mediated Degradation of RhoA and Stabilization of PAR6.
Kaiser J; Maibach M; Piovesana E; Salpeter I; Escher N; Ormen Y; Schwab ME
eNeuro; 2020; 7(5):. PubMed ID: 32887692
[TBL] [Abstract][Full Text] [Related]
3. Autocrine regulation of biliary pathology by activated cholangiocytes.
Jensen K; Marzioni M; Munshi K; Afroze S; Alpini G; Glaser S
Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(5):G473-83. PubMed ID: 22194419
[TBL] [Abstract][Full Text] [Related]
4. Genetic and molecular abnormalities in cholangiocarcinogenesis.
Hassid VJ; Orlando FA; Awad ZT; Tan D; Khoury T; Ahmed BH; Alrawi SJ
Anticancer Res; 2009 Apr; 29(4):1151-6. PubMed ID: 19414358
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells.
Lang M; Henson R; Braconi C; Patel T
Liver Int; 2009 May; 29(5):670-7. PubMed ID: 19226332
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2.
Voutsadakis IA
J Cell Mol Med; 2007; 11(2):252-85. PubMed ID: 17488476
[TBL] [Abstract][Full Text] [Related]
7. Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways.
Naus PJ; Henson R; Bleeker G; Wehbe H; Meng F; Patel T
J Hepatol; 2007 Feb; 46(2):222-9. PubMed ID: 17069924
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor B1 stimulated DNA synthesis in the granulosa cells of preantral follicles: negative interaction with epidermal growth factor.
Yang P; Roy SK
Biol Reprod; 2006 Jul; 75(1):140-8. PubMed ID: 16525033
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.
Meng F; Yamagiwa Y; Ueno Y; Patel T
J Hepatol; 2006 Jun; 44(6):1055-65. PubMed ID: 16469407
[TBL] [Abstract][Full Text] [Related]
10. The role of p27Kip1 in proteasome inhibitor induced apoptosis.
Drexler HC
Cell Cycle; 2003; 2(5):438-41. PubMed ID: 12963837
[TBL] [Abstract][Full Text] [Related]
11. On and off: proteasome and TGF-beta signaling.
Zhang F; Laiho M
Exp Cell Res; 2003 Dec; 291(2):275-81. PubMed ID: 14644150
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta inhibition of proteasomal activity: a potential mechanism of growth arrest.
Tadlock L; Yamagiwa Y; Hawker J; Marienfeld C; Patel T
Am J Physiol Cell Physiol; 2003 Aug; 285(2):C277-85. PubMed ID: 12646415
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta induced G(1) cell cycle arrest requires the activity of the proteasome pathway. Transforming growth factor.
Zhang F; Mönkkönen M; Roth S; Laiho M
Exp Cell Res; 2002 Dec; 281(2):190-6. PubMed ID: 12460649
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of three peptidase activities of the proteasome in human lens epithelium by heat and oxidation.
Andersson M; Sjöstrand J; Karlsson JO
Exp Eye Res; 1999 Jul; 69(1):129-38. PubMed ID: 10375457
[TBL] [Abstract][Full Text] [Related]
15. Proteasomal activity modulates TGF-ss signaling in a gene-specific manner.
Zhang F; Mönkkönen M; Roth S; Laiho M
FEBS Lett; 2002 Sep; 527(1-3):58-62. PubMed ID: 12220633
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
